Nadine Rohwer
Neuruppin, BB 16816, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
FBiosynthesis and analytics of specialized pro-resolving mediators: facts and faults.
Journal: Journal of lipid research
Published: June 24, 2026
Corrigendum to "Prevention of colitis-induced liver oxidative stress and inflammation in a transgenic mouse model with increased omega-3 polyunsaturated fatty acids" [Redox Biol. 64 (2023) 102803].
Journal: Redox biology
Published: February 02, 2026
Ketone ester supplementation protects from experimental colitis via improved goblet cell differentiation and function.
Journal: European journal of nutrition
Published: May 20, 2025
An Optimized Ex Vivo n-3 PUFA Supplementation Strategy for Primary Human Macrophages Shows That DHA Suppresses Prostaglandin E2 Formation.
Journal: Molecular nutrition & food research
Published: September 05, 2024
Harnessing Oxylipins and Inflammation Modulation for Prevention and Treatment of Colorectal Cancer.
Journal: International journal of molecular sciences
Published: January 29, 2024
Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.
Journal: Frontiers in pharmacology
Published: December 12, 2023
Ketogenic Diet Has Moderate Effects on the Fecal Microbiota of Wild-Type Mice.
Journal: Nutrients
Published: September 28, 2023
Prevention of colitis-induced liver oxidative stress and inflammation in a transgenic mouse model with increased omega-3 polyunsaturated fatty acids.
Journal: Redox biology
Published: May 19, 2023
Transgenic mice overexpressing human ALOX15 under the control of the aP2 promoter are partly protected in the complete Freund's adjuvant-induced paw inflammation model.
Journal: Inflammation research : official journal of the European Histamine Research Society ... [et al.]
Published: May 12, 2023
Bioactive oxylipins in type 2 diabetes mellitus patients with and without hypertriglyceridemia.
Journal: Frontiers in endocrinology
Published: March 28, 2023
Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma.
Journal: Frontiers in pharmacology
Published: December 14, 2022
Last Updated: 09/26/2026